Clinical Trials Directory

Trials / Recruiting

RecruitingNCT07250126

3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT)

Status
Recruiting
Phase
Study type
Observational
Enrollment
5 (estimated)
Sponsor
I.R.C.C.S Ospedale Galeazzi-Sant'Ambrogio · Academic / Other
Sex
All
Age
30 Years – 70 Years
Healthy volunteers
Not accepted

Summary

The general objective of this project is to define the transcriptional profile of primary human cells derived from the nucleus pulposus (NP), annulus fibrosus (AF), and cartilaginous endplate (CEP), and to use this information as a reference to assess the biological relevance of a biomimetic spinal unit model obtained through bioprinting. By developing an in vitro model of human origin that incorporates key components of the spinal unit and applying transcriptional analyses to both native cells and their counterparts recovered from the 3D construct, the study will evaluate how accurately the bioprinted model reproduces the identity and heterogeneity of the native discal environment.

Conditions

Timeline

Start date
2025-11-04
Primary completion
2027-10-01
Completion
2027-10-01
First posted
2025-11-26
Last updated
2025-11-26

Locations

1 site across 1 country: Italy

Source: ClinicalTrials.gov record NCT07250126. Inclusion in this directory is not an endorsement.

3D Biomimetic Spine Unit Model Through the Integration of Bioprinting and Transcriptomics (CDP-SUBT) (NCT07250126) · Clinical Trials Directory